C
Christopher Semsarian
Researcher at University of Sydney
Publications - 439
Citations - 20005
Christopher Semsarian is an academic researcher from University of Sydney. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Sudden cardiac death. The author has an hindex of 56, co-authored 367 publications receiving 15292 citations. Previous affiliations of Christopher Semsarian include Royal Prince Alfred Hospital & University of Melbourne.
Papers
More filters
Journal ArticleDOI
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Michael J. Ackerman,Silvia G. Priori,Stephan Willems,Charles I. Berul,Ramon Brugada,Hugh Calkins,A. John Camm,Patrick T. Ellinor,Michael H. Gollob,Robert J. Hamilton,Ray E. Hershberger,Daniel P. Judge,Daniel P. Judge,Hervé Le Marec,William J. McKenna,Eric Schulze-Bahr,Christopher Semsarian,Jeffrey A. Towbin,Hugh Watkins,Arthur A.M. Wilde,Christian Wolpert,Douglas P. Zipes +21 more
TL;DR: This dissertation aims to provide a history of modern medicine and some of the techniques and practices used in modern medicine, as well as some new approaches, that were introduced in the field of medicine more than 40 years ago.
Journal ArticleDOI
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies
Michael J. Ackerman,Silvia G. Priori,Stephan Willems,Charles I. Berul,Ramon Brugada,Hugh Calkins,A. John Camm,Patrick T. Ellinor,Michael H. Gollob,Robert Hamilton,Ray E. Hershberger,Daniel P. Judge,Daniel P. Judge,Hervé Le Marec,William J. McKenna,Eric Schulze-Bahr,Christopher Semsarian,Jeffrey A. Towbin,Hugh Watkins,Arthur A.M. Wilde,Christian Wolpert,Douglas P. Zipes +21 more
TL;DR: This international consensus statement provides the state of genetic testing for the channelopathy and cardiomyopathies and summarizes the opinion of the international writing group members based on their own experience and on a general review of the literature with respect to the use and role of geneticTesting for these potentially heritable cardiac conditions.
Journal ArticleDOI
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
TL;DR: It is suggested that HCM is more common than previously estimated, which may enhance its recognition in the practicing cardiovascular community, allowing more timely diagnosis and the implementation of appropriate treatment options for many patients.
Journal ArticleDOI
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
Barry J. Maron,Paolo Spirito,Win Kuang Shen,Tammy S. Haas,Francesco Formisano,Mark S. Link,Andrew E. Epstein,Adrian K. Almquist,James P. Daubert,Thorsten Lawrenz,Giuseppe Boriani,N.A. Mark Estes,Stefano Favale,Marco Piccininno,Stephen L. Winters,Massimo Santini,Sandro Betocchi,Fernando Arribas,Mark V. Sherrid,Gianfranco Buja,Christopher Semsarian,Paolo Bruzzi +21 more
TL;DR: In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm.
Journal ArticleDOI
Genetics of Hypertrophic Cardiomyopathy After 20 Years: Clinical Perspectives
TL;DR: Genotyping in HCM can be a powerful tool for family screening and diagnosis, however, wider adoption and future success of genetic testing in the practicing cardiovascular community depends on a standardized approach to mutation interpretation, and bridging the communication gap between basic scientists and clinicians.